multiple myeloma
Multiple Myeloma Research Foundation Awards $21M in Research Grants
The grants will support research using omics and other technologies to study and treat different forms of multiple myeloma including high-risk disease.
Allogeneic Stem Cell Transplant Outcomes Improve With Diverse Gut Microbes, Immune Cells
By profiling the gut microbiome and blood immune cells, researchers found features linked to good outcomes and lower graft-versus-host disease rates.
The Seattle-based company recently completed a strategic reorganization around its two major business areas by cutting the workforce and appointing a new CFO.
Genetron Health Nabs CE Mark for Blood Cancer Residual Disease Test Kit
The assay uses the company's "One-step Seq" method to detect cancer-associated DNA sequences in bone marrow from patients with certain hematologic cancers.
Adaptive Biotechnologies to Focus on Immune Medicine, Minimal Residual Disease Testing Businesses
Premium
The Seattle-based company said this week that its immune medicine and minimal residual disease testing business arms will drive the firm's future growth.